Study of ABO2102 in KRAS-Mutated Solid Tumors

Clinical trial NCT07455617 · RECRUITING

Trial details

NCT number: NCT07455617
Sponsor: Suzhou Abogen Biosciences Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced / Metastatic Solid Tumor

Start date: 2026-03-24
Primary completion: 2029-06-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.